Reno, Nev. (PRWEB) August 26, 2013
First Warning Systems, Inc. (FWS), a Reno-based life sciences software and medical device company, recently retained Joshua D. I. Ellenhorn, M.D., as the Principal Investigator (PI) in preparation for the anticipated clinical validation studies slated for later this year. This is the latest development in FWS’ progress toward the realization of its non-invasive, intelligent, wearable, biofeedback early breast cancer screening device. Retention of an expert PI is a critical step toward bringing FWS’ proprietary breast health product and service to market in the near term.
Ellenhorn, a leading expert in surgical oncology, has been at the forefront of breast cancer treatment for years. In addition to being Clinical Professor of Surgery at Cedars-Sinai Medical Center and Adjunct Professor at the John Wayne Cancer Center, Ellenhorn has directed extensive laboratory research to develop new cancer vaccines that work on the immune system to identify and eliminate cancer cells. U.S. News & World Report ranks him among the top one percent of surgeons in the United States and he is ranked as a Super Doctor in Los Angeles. A medical educator, Ellenhorn has trained over 60 surgical oncologists.
The sum of his extensive qualifications positions Ellenhorn to be a driving force for the advancement of the FWS technology, which has concluded three successful clinical trials as well as completed over five years of advanced algorithm development in preparation for launch.
“The technology shows significant promise of supplementing today's imaging standards for a more concise early prediction of breast cancer,” said Ellenhorn. “We are anticipating engaging a multi-center trial to ensure a timely and accurate outcome to our validation trial.”
First Warning Sys
Copyright©2012 Vocus, Inc.
All rights reserved